MS4A1 and neoplasm: Pretscher and colleagues demonstrated the association of increased peritumoral CD20+ B-cell presence in HNSCC metastatic lymph nodes with prolonged disease-free survival [62], a finding that was confirmed by an additional study by Suárez-Sánchez et al., where CD20+ primary-tumor-infiltrating B-cells were associated with improved disease-specific survival [63].